ST6GAL1 and urinary bladder carcinoma: Finally, demethylating treatment of methylated ST6GAL1 bladder cancer cell lines with 5-aza-2-deoxycytidine clearly restored ST6GAL1 expression, thus functionally confirming a strong correlation between ST6GAL1 expression and its promoter hypermethylation.